103 related articles for article (PubMed ID: 29610525)
21. CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells.
Xie J; Lan T; Zheng DL; Ding LC; Lu YG
BMC Oral Health; 2023 May; 23(1):329. PubMed ID: 37237299
[TBL] [Abstract][Full Text] [Related]
22. Association of environmental exposure to chromium with differential DNA methylation: An epigenome-wide study.
Zhao M; Wu J; Xu J; Li A; Mei Y; Ge X; Yin G; Liu X; Wei L; Xu Q
Front Genet; 2022; 13():1043486. PubMed ID: 36685967
[No Abstract] [Full Text] [Related]
23. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway.
Li Y; Yang S; Yang S
Cells; 2022 Apr; 11(8):. PubMed ID: 35456040
[TBL] [Abstract][Full Text] [Related]
24. Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer.
Ding JH; Xiao Y; Zhao S; Xu Y; Xiao YL; Shao ZM; Jiang YZ; Di GH
Mol Ther Oncolytics; 2022 Mar; 24():624-635. PubMed ID: 35284626
[TBL] [Abstract][Full Text] [Related]
25. Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma.
Li F; Wan B; Li XQ
Dis Markers; 2022; 2022():9644466. PubMed ID: 35242247
[TBL] [Abstract][Full Text] [Related]
26. Osteosarcoma and Metastasis.
Sheng G; Gao Y; Yang Y; Wu H
Front Oncol; 2021; 11():780264. PubMed ID: 34956899
[TBL] [Abstract][Full Text] [Related]
27. Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA.
Wang J; Yuan L; Xu X; Zhang Z; Ma Y; Hong L; Ma J
Cell Death Dis; 2021 Dec; 12(12):1148. PubMed ID: 34893584
[TBL] [Abstract][Full Text] [Related]
28. miR-877-3p inhibits tumor growth and angiogenesis of osteosarcoma through fibroblast growth factor 2 signaling.
Chen M; Li Z; Cao L; Fang C; Gao R; Liu C
Bioengineered; 2022 Apr; 13(4):8174-8186. PubMed ID: 34738872
[TBL] [Abstract][Full Text] [Related]
29. Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion.
Lavoie RR; Gargollo PC; Ahmed ME; Kim Y; Baer E; Phelps DA; Charlesworth CM; Madden BJ; Wang L; Houghton PJ; Cheville J; Dong H; Granberg CF; Lucien F
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572755
[TBL] [Abstract][Full Text] [Related]
30. Mithramycin delivery systems to develop effective therapies in sarcomas.
Estupiñán Ó; Niza E; Bravo I; Rey V; Tornín J; Gallego B; Clemente-Casares P; Moris F; Ocaña A; Blanco-Lorenzo V; Rodríguez-Santamaría M; Vallina-Álvarez A; González MV; Rodríguez A; Hermida-Merino D; Alonso-Moreno C; Rodríguez R
J Nanobiotechnology; 2021 Sep; 19(1):267. PubMed ID: 34488783
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA FER1L4 promotes the malignant processes of papillary thyroid cancer by targeting the miR-612/ Cadherin 4 axis.
Wu L; Ding Y; Tong H; Zhuang X; Cai J; Si Y; Zhang H; Wang X; Shen M
Cancer Cell Int; 2021 Jul; 21(1):392. PubMed ID: 34289835
[TBL] [Abstract][Full Text] [Related]
32. Advanced maternal age causes premature placental senescence and malformation via dysregulated α-Klotho expression in trophoblasts.
Chen Z; Xiong L; Jin H; Yu J; Li X; Fu H; Wen L; Qi H; Tong C; Saffery R; Kilby MD; Baker PN
Aging Cell; 2021 Jul; 20(7):e13417. PubMed ID: 34105233
[TBL] [Abstract][Full Text] [Related]
33. Gankyrin activates the hedgehog signalling to drive metastasis in osteosarcoma.
Wang C; Jing J; Hu X; Yu S; Yao F; Li Z; Cheng L
J Cell Mol Med; 2021 Jul; 25(13):6232-6241. PubMed ID: 34089292
[TBL] [Abstract][Full Text] [Related]
34. Theragnostic chromosomal rearrangements in treatment-naive pancreatic ductal adenocarcinomas obtained via endoscopic ultrasound.
Murphy SJ; Levy MJ; Smadbeck JB; Karagouga G; McCune AF; Harris FR; Udell JB; Johnson SH; Kerr SE; Cheville JC; Kipp BR; Vasmatzis G; Gleeson FC
J Cell Mol Med; 2021 Apr; 25(8):4110-4123. PubMed ID: 33704908
[TBL] [Abstract][Full Text] [Related]
35. RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling.
Li Y; Liu M; Yang S; Fuller AM; Karin Eisinger-Mathason TS; Yang S
Oncogene; 2021 Apr; 40(14):2553-2566. PubMed ID: 33686240
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of wild type or a Q311E mutant MB21D2 promotes a pro-oncogenic phenotype in HNSCC.
Gracilla DE; Korla PK; Lai MT; Chiang AJ; Liou WS; Sheu JJ
Mol Oncol; 2020 Dec; 14(12):3065-3082. PubMed ID: 32979859
[TBL] [Abstract][Full Text] [Related]
37. Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma.
Zhou X; Huang H; Cui W; Wang Y; Luo W; Matskova L; Zhou X
Med Sci Monit; 2020 Jun; 26():e922836. PubMed ID: 32511216
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone receptor promotes osteosarcoma cell growth and metastases.
Cheng M; Huang W; Cai W; Fang M; Chen Y; Wang C; Yan W
FEBS Open Bio; 2020 Jan; 10(1):127-134. PubMed ID: 31725956
[TBL] [Abstract][Full Text] [Related]
39. Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells.
Ceresa D; Alessandrini F; Bosio L; Marubbi D; Reverberi D; Malatesta P; Appolloni I
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426573
[TBL] [Abstract][Full Text] [Related]
40. LncRNA-miRNA-mRNA expression variation profile in the urine of calcium oxalate stone patients.
Liang X; Lai Y; Wu W; Chen D; Zhong F; Huang J; Zeng T; Duan X; Huang Y; Zhang S; Li S; Wu W
BMC Med Genomics; 2019 Apr; 12(1):57. PubMed ID: 31036010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
